Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Maria Pelizzari, A."'
Autor:
Raphael Itzykson, Valeria Santini, Sylvain Thepot, Lionel Ades, Cendrine Chaffaut, Aristoteles Giagounidis, Margot Morabito, Nathalie Droin, Michael Lübbert, Rosa Sapena, Stanislas Nimubona, Jean Goasguen, Eric Wattel, Gina Zini, Jose Miguel Torregrosa Diaz, Ulrich Germing, Anna Maria Pelizzari, Sophie Park, Nadja Jaekel, Georgia Metzgeroth, Francesco Onida, Robert Navarro, Andrea Patriarca, Aspasia Stamatoullas, Katharina Götze, Martin Puttrich, Sandra Mossuto, Eric Solary, Silke Gloaguen, Sylvie Chevret, Fatiha Chermat, Uwe Platzbecker, Pierre Fenaux
Publikováno v:
Journal of Clinical Oncology. 41:1888-1897
PURPOSE Hydroxyurea (HY) is a reference treatment of advanced myeloproliferative neoplasms. We conducted a randomized phase III trial comparing decitabine (DAC) and HY in advanced myeloproliferative chronic myelomonocytic leukemias (CMML). PATIENTS A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c68d965285ffda567a7059371bff94e
https://doi.org/10.1200/jco.22.00437
https://doi.org/10.1200/jco.22.00437
Autor:
Luca Lanino, Prassede Salutari, Alessandra Perego, Bruno Fattizzo, Marta Riva, Marta Ubezio, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Maria Teresa Voso, Anna Maria Pelizzari, Antonella Poloni, Isabella Capodanno, Chiara Elena, Claudio Fozza, Fabrizio Pane, Massimo Breccia, Marco De Gobbi, Francesco Di Bassiano, Daniela Barraco, Elena Crisà, Dario Ferrero, Chiara Frairia, Antonella Vaccarino, Davide Griguolo, Stefania Paolini, Martina Quintini, Mariarosaria Sessa, Mauro Turrini, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Cristina Foli, Alfredo Molteni, Ubaldo Occhini, Giulia Rivoli, Carmine Selleri, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Alessandro Rambaldi, Ilaria Tanasi, Patrizia Tosi, Ilaria Naldi, Valeria Santini, Matteo G. Della Porta
Publikováno v:
Blood. 140:6945-6948
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e3d8b261e1bc8753449a28450b621a7
https://doi.org/10.1182/blood-2022-164559
https://doi.org/10.1182/blood-2022-164559
Autor:
Anna Maria Pelizzari, Monica Drera, Mariella D’Adda, Marco Ungari, Daniela Marocolo, Fabio Facchetti, Daniela Bellotti, Sergio Barlati, Giuseppe Rossi
Publikováno v:
Haematologica, Vol 92, Iss 1 (2007)
Twenty-five elderly patients with oligoblastic acute myeloid leukemia (AML) received subcutaneous granulocyte colony-stimulating factor (filgrastim) in addition to supportive care. Ninety-two percent of the patients had multilineage dysplasia, 17% hy
Externí odkaz:
https://doaj.org/article/9e113159a8a54c4c883037db9927fc4a
Autor:
Arcioni, F., Roncadori, A., Di Battista, V., Tura, S., Covezzoli, A., Cundari, S., Mecucci, C., Abbadessa, A., Alterini, R., Santini, V., Cantonetti, M., Buccisano, F., Bacigalupo, A., Sessarego, M., Tonso, A., Ferrero, D., D'Ardia, S., Tarella, C., Cascavilla, N., Bassan, R., Sancetta, R., Cortelezzi, A., Reda, G., Maria D'Arco, A., De Fabritiis, P., Di Renzo, N., Falini, B., Alimena, G., Avanzini, P., Ilariucci, F., Iuliano, F., La Nasa, G., Caocci, G., Defina, M., Latte, G., Palmas, A., Levis, A., Leone, G., Teresa Voso, M., Leoni, P., Poloni, A., Fozza, C., Crugnola, M., Montanaro, M., Spedini, P., Lanza, F., Pizzuti, M., Pane, F., Paolini, R., Borin, L., Rambaldi, A., Rossi, G., Maria Pelizzari, A., Russo, D., D'Emilio, A., Ruggeri, M., Semenzato, G., Specchia, G., Tagariello, G., Sartori, R., Testore, F., Ciravegna, G., Marasca, R., Cimarosto, L., Fontanive, O., Visani, G.
Objective The most typical cytogenetic aberration in myelodysplastic syndromes is del(5q), which, when isolated, is associated with refractory anaemia and good prognosis. Based on high rates of erythroid response and transfusion independence, Lenalid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3eff6995b50422779788d1e684e3475
http://hdl.handle.net/11391/1434712
http://hdl.handle.net/11391/1434712
Autor:
Jean E. Goasguen, Anna Maria Pelizzari, Francesco Onida, Pierre Fenaux, Raphael Itzykson, Cendrine Chaffaut, Stanislas Nimubona, Aspasia Stamatoulas Bastard, Eric Wattel, Fatiha Chermat, Sandra Mossuto, Margot Morabito, Ades Lionel, Aristoteles Giagounidis, Nathalie Droin, Valeria Santini, Sophie Park, Sylvain Thepot, Sylvie Chevret, Georgia Metzgeroth, Ulrich Germing, Rosa Sapena, Jose Miguel Torregrosa Diaz, Andrea Patriarca, Nadja Jaekel, Uwe Platzbecker, Silke Gloaguen, Robert Navarro, Eric Solary, Martin Puttrich, Michael Luebbert, Gina Zini
Publikováno v:
Blood. 136:53-54
Context. The perhaps only CMML-specific Randomized Clinical Trial (RCT) established hydroxyurea (HY) as the main treatment (Tx) for advanced proliferative CMML (Wattel Blood 1996). In Europe, the only hypomethylating agent (HMA) approved in CMML is A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b6835b0e38975f8ebfeedbcd23e6c58
https://doi.org/10.1182/blood-2020-138680
https://doi.org/10.1182/blood-2020-138680
Autor:
Maria L. La Targia, Giulia Quaresmini, Giuliana Muti, Anna Maria Pelizzari, Maria C. Vilardo, Eraldo Lanzi, Giuseppe Danilo Vighi, Nicola Stefano Fracchiolla, Niccolò Frungillo, M.C. Pasquini, Roberta Gaiardoni, Agostino Cortelezzi, Maurizio Bonfichi, Alessandra Ragazzi, Silvia Artuso, Dario Consonni, Federica Bocchio, Lucia Prestini, Claudia Bacci, Simona Sammassimo, Giacomo Berini, Daniele Boghi, Alessia Pastore, Alma Lisa Rivolta, Giuseppe Gritti, Massimo Magagnoli, Simone Voltolini, Elisa De Rosa, Paola Tozzi, Consuelo Corti, Livio Gargantini
Publikováno v:
Hematological oncology. 36(1)
Adverse drug reactions (ADRs) reduce patients' quality of life, increase mortality and morbidity, and have a negative economic impact on healthcare systems. Nevertheless, the importance of ADR reporting is often underestimated. The project "FarmaREL"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c692a28bd843e8629325b1e22135c95e
https://pubmed.ncbi.nlm.nih.gov/28771763
https://pubmed.ncbi.nlm.nih.gov/28771763
Autor:
Chiara, Cattaneo, Doriana, Gramegna, Chiara, Pagani, Erika, Borlenghi, Malagola, Michele, Elisa, Cerqui, Angela, Passi, Schieppati, Francesca, Claudia, Crippa, Daniela, Dalceggio, Cecilia, Carbone, Anna Maria Pelizzari, Margherita, Sciumé, Alessandro, Re, Russo, Domenico, Giuseppe, Rossi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3662::25b521b04acdf2b98b578c8a2733ed9f
http://hdl.handle.net/11379/528191
http://hdl.handle.net/11379/528191
Autor:
Alessandra Freyrie, Emanuele Ravano, Enrica Morra, Roberto Cairoli, Jacopo Mariotti, Marta Ubezio, Rosa Greco, Matteo G. Della Porta, Domenica Caramazza, Massimo Bernardi, Marta Riva, Simona Guarco, Alfredo Molteni, Lorenza Borin, Giulia Quaresmini, Michele Nichelatti, Federica Gigli, Anna Maria Pelizzari
5-Azacytidine is an effective therapy in high risk MDS and oligoblastic AML. This "real life" analysis was made on 185 patients treated with 5-azacytidine in 10 centers afferent to REL ("Rete Ematologica Lombarda"), a network in Lombardia region. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9c784a5932365497e9234327d18d7e
https://hdl.handle.net/10281/408713
https://hdl.handle.net/10281/408713
Autor:
Laura Broglio, Anna Maria Pelizzari, Alessandro Padovani, Michelangelo Mancuso, Massimiliano Filosto, Mauro Scarpelli, Giuseppe Rossi, M. Rinaldi, Marta Tentorio, Serena Buzio
Publikováno v:
Journal of the Neurological Sciences. 263:40-43
Bortezomib, a proteasome inhibitor used in the treatment of multiple myeloma, is known to induce an axonal, dose-dependent neuropathy clinically characterized by pain, paresthesias, burning dysesthesias and numbness. In this study, we describe a pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788db2752ebf70200aec775a16a5814a
https://doi.org/10.1016/j.jns.2007.05.023
https://doi.org/10.1016/j.jns.2007.05.023
Autor:
Elisabetta Cariani, Anna Maria Pelizzari, Erika Borlenghi, Paola Turconi, Maddalena Motta, Giuseppe Rossi
Publikováno v:
The Hematology Journal. 5:325-328
Hepatitis B virus (HBV) reactivation is a potentially fatal complication of chemotherapy in asymptomatic HBV carriers. Prophylactic lamivudine has proven effective for its prevention, but the potential emergence of lamivudine-resistant HBV YMMD mutan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1ff97c3c8ef43240e8bc864a700030
https://doi.org/10.1038/sj.thj.6200396
https://doi.org/10.1038/sj.thj.6200396